Mindy I Davis, PhD
About Mindy I Davis, PhD
Mindy I Davis, PhD, serves as a Program Officer in Antiviral Discovery at the National Institutes of Health since 2016. With a strong background in biochemistry and extensive experience in research and editorial roles, she specializes in assay artifact detection, structural biology, and various analytical techniques.
Work at National Institutes of Health
Mindy I Davis, PhD, has been serving as a Program Officer in Antiviral Discovery at the National Institutes of Health since 2016. In this role, she focuses on overseeing and advancing research initiatives related to antiviral drug development. Her extensive background in biochemistry and drug discovery supports her contributions to the NIH's mission of improving public health through scientific research. Prior to her current position, she worked at the NIH as a Senior Research Scientist/Biochemist from 2010 to 2016.
Education and Expertise
Mindy I Davis holds a Ph.D. in Inorganic Chemistry from Stanford University, where she studied from 1995 to 2001. She also completed a Post-Doctoral position at the California Institute of Technology from 2002 to 2005. Additionally, she has obtained various certificates in Drug Discovery and Development from the University of California, San Diego. Her expertise includes assay artifact detection, structural biology, spectroscopy, protein crystallization, computational chemistry, enzymology, and biophysical characterization.
Previous Work Experience
Before her tenure at the National Institutes of Health, Mindy I Davis worked in several research and editorial roles. She served as a Senior Research Scientist at Ambit Biosciences from 2005 to 2010. She also held positions at the NIH as a Senior Research Scientist/Biochemist and worked as an Editor at American Journal Experts from 2010 to 2013. Earlier in her career, she gained experience through internships at Eastman Kodak and Unilever, as well as a UROP position at MIT.
Certifications and Skills
Mindy I Davis holds a FAC-COR level II certification, demonstrating her advanced knowledge in federal acquisition and contract management. Her skill set encompasses a range of scientific techniques, including structural biology, spectroscopy, protein crystallization, and computational chemistry. She is proficient in enzymology and mechanism of action studies, focusing on the biochemical processes of enzyme catalysis. Her background in biophysical characterization further enhances her capabilities in analyzing biological molecules.